Volume 18, Number 1—January 2012
Research
High Prevalence of Multidrug-Resistant Tuberculosis, Swaziland, 2009–2010
Table 1
Characteristic | New, n = 420 | Previously treated, n = 420 | Total, n = 840 |
---|---|---|---|
Median age, y | 32 (IQR 26–40) | 33 (IQR 28–43) | 33 (IQR 27–41) |
Sex | |||
M | 206 (49.0) | 196 (46.7) | 402 (47.9) |
F | 214 (51.0) | 224 (53.3) | 438 (52.1) |
Region of residence | |||
Shiselweni | 106 (25.2) | 96 (22.9) | 202 (24.0) |
Manzini | 106 (25.2) | 119 (28.3) | 225 (26.8) |
HhoHho | 120 (28.6) | 109 (26.0) | 229 (27.3) |
Lubombo | 86 (20.5) | 96 (22.9) | 182 (21.7) |
Unknown | 2 (0.5) | 0 | 2 (0.2) |
Education | |||
None | 97 (23.1) | 75 (17.9) | 172 (20.5) |
Primary school | 144 (34.3) | 145 (34.5) | 289 (34.4) |
Secondary school | 104 (24.8) | 112 (26.7) | 216 (25.7) |
High school | 62 (14.8) | 56 (13.3) | 118 (14.0) |
Tertiary | 10 (2.4) | 19 (4.5) | 29 (3.5) |
Unknown | 3 (0.7) | 13 (3.1) | 16 (1.9) |
Employment (permanent job) | |||
No | 285 (67.9) | 293 (69.8) | 578 (68.8) |
Yes | 127 (30.2) | 115 (27.4) | 242 (28.8) |
Unknown | 8 (1.9) | 12 (2.9) | 20 (2.4) |
HIV-positive status known | 279/316 (77.3) | 327/397 (82.4) | 606/758 (79.9) |
Previous anti-TB treatment courses | |||
1 | 352 (83.8) | ||
2 | 39 (9.3) | ||
>2 | 14 (3.3) | ||
Unknown | 15 (3.6) | ||
Previous TB treatment regimen | |||
Category I | 349 (83.1) | ||
Category II | 60 (14.3) | ||
MDR | 3 (0.7) | ||
Other | 8 (1.9) | ||
Outcome of most recent TB treatment | |||
Cured | 76 (18.1) | ||
Completed | 158 (37.6) | ||
Failed category I | 109 (26.0) | ||
Failed category II | 11 (2.6) | ||
Defaulted | 45 (10.7) | ||
Unknown | 21 (5.0) |
*Values are no. (%) or no. positive/no. tested (%) unless otherwise indicated. MDR, multidrug resistant; TB, tuberculosis; IQR, interquartile range.
Page created: December 16, 2011
Page updated: December 16, 2011
Page reviewed: December 16, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.